TIM
BIIB icon

Tevis Investment Management’s Biogen BIIB Stock Holding History

Tevis Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,340
Closed -$454K – 98
2024
Q3 		$454K Buy
2,340
+13
+0.6% +$2.72K 0.34% 70
2024
Q2 		$539K Sell
2,327
-99
-4% -$21.5K 0.43% 63
2024
Q1 		$523K Sell
2,426
-11
-0.5% -$2.58K 0.44% 63
2023
Q4 		$631K Sell
2,437
-3
-0.1% -$737 0.58% 52
2023
Q3 		$627K Sell
2,440
-9
-0.4% -$2.41K 0.64% 53
2023
Q2 		$698K Buy
2,449
+8
+0.3% +$2.38K 0.68% 49
2023
Q1 		$679K Hold
2,441
– – 0.69% 49
2022
Q4 		$676K Sell
2,441
-81
-3% -$22.9K 0.72% 48
2022
Q3 		$673K Buy
2,522
+49
+2% +$10.4K 0.65% 50
2022
Q2 		$504K Buy
2,473
+154
+7% +$31.5K 0.48% 61
2022
Q1 		$490K Buy
2,319
+79
+4% +$17.2K 0.44% 65
2021
Q4 		$536K Buy
+2,240
New +$576K 0.47% 68

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tevis Investment Management's BIIB Position: Q4 2024 in Review

Tevis Investment Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,340 shares — an estimated $454K sold.

Tevis Investment Management first reported a position in BIIB in Q4 2021 and held it in 12 quarters. The position peaked at $698K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Tevis Investment Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Tevis Investment Management sold 2,340 Biogen shares in Q4 2024, an estimated $454K.
  • Tevis Investment Management first reported a position in Biogen in Q4 2021 and held it in 12 quarters.
  • Tevis Investment Management's Biogen position peaked at $698K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Tevis Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.